Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Echo Lab, Department of Ultrasound Imaging, Renmin Hospital of Wuhan University, Wuhan, China.
Front Immunol. 2023 Sep 7;14:1248056. doi: 10.3389/fimmu.2023.1248056. eCollection 2023.
The prevalence of ischemic heart disease has reached pandemic levels worldwide. Early revascularization is currently the most effective therapy for ischemic heart diseases but paradoxically induces myocardial ischemia/reperfusion (MI/R) injury. Cardiac inflammatory reaction and oxidative stress are primarily involved in the pathology of MI/R injury. Low-intensity pulsed ultrasound (LIPUS) has been demonstrated to reduce cell injury by protecting against inflammatory reaction and oxidative stress in many diseases, including cardiovascular diseases, but rarely on MI/R injury.
This study was designed to clarify whether LIPUS alleviates MI/R injury by alleviating inflammatory reaction and oxidative stress. Simultaneously, we have also tried to confirm which intensity of the LIPUS might be more suitable to ameliorate the MI/R injury, as well as to clarify the signaling mechanisms. MI/R and simulated ischemia/reperfusion (SI/R) were respectively induced in Sprague Dawley rats and human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs). LIPUS treatment, biochemical measurements, cell death assay, estimation of cardiac oxidative stress and inflammatory reaction, and protein detections by western blotting were performed according to the protocol.
In our study, both in vivo and in vitro, LIPUS of 0.1 W/cm (LIPUS) and 0.5 W/cm (LIPUS) make no significant difference in the cardiomyocytes under normoxic condition. Under the hypoxic condition, MI/R injury, inflammatory reaction, and oxidative stress were partially ameliorated by LIPUS but were significantly aggravated by LIPUS of 2.5 W/cm (LIPUS) both in vivo and in vitro. The activation of the apoptosis signal-regulating kinase 1 (ASK1)/c-Jun N-terminal kinase (JNK) pathway in cardiomyocytes with MI/R injury was partly rectified LIPUS both in vivo and in vitro.
Our study firstly demonstrated that LIPUS of different intensities differently affects MI/R injury by regulating cardiac inflammatory reaction and oxidative stress. Modulations on the ASK1/JNK pathway are the signaling mechanism by which LIPUS exerts cardioprotective effects. LIPUS is promising for clinical translation in protecting against MI/R injury. This will be great welfare for patients suffering from MI/R injury.
缺血性心脏病的患病率在全球范围内已达到流行水平。目前,早期血运重建是治疗缺血性心脏病最有效的方法,但却会诱发心肌缺血/再灌注(MI/R)损伤。心脏炎症反应和氧化应激主要参与 MI/R 损伤的病理过程。低强度脉冲超声(LIPUS)已被证明可通过减轻炎症反应和氧化应激来减少多种疾病(包括心血管疾病)中的细胞损伤,但很少应用于 MI/R 损伤。
本研究旨在阐明 LIPUS 是否通过减轻炎症反应和氧化应激来减轻 MI/R 损伤。同时,我们还试图确定哪种强度的 LIPUS 更适合改善 MI/R 损伤,并阐明其信号机制。在 Sprague Dawley 大鼠和人多能干细胞衍生的心肌细胞(hPSC-CMs)中分别诱导 MI/R 和模拟缺血/再灌注(SI/R)。根据方案进行 LIPUS 处理、生化测量、细胞死亡测定、心脏氧化应激和炎症反应评估以及蛋白质的 Western blot 检测。
在本研究中,无论是在体内还是在体外,0.1 W/cm(LIPUS)和 0.5 W/cm(LIPUS)的 LIPUS 在常氧条件下对心肌细胞没有显著影响。在缺氧条件下,LIPUS 部分改善了 MI/R 损伤、炎症反应和氧化应激,但在体内和体外,2.5 W/cm(LIPUS)的 LIPUS 显著加重了这些损伤。在伴有 MI/R 损伤的心肌细胞中,凋亡信号调节激酶 1(ASK1)/c-Jun N-末端激酶(JNK)通路的激活被 LIPUS 在体内和体外部分纠正。
本研究首次表明,不同强度的 LIPUS 通过调节心脏炎症反应和氧化应激,对 MI/R 损伤产生不同的影响。ASK1/JNK 通路的调节是 LIPUS 发挥心脏保护作用的信号机制。LIPUS 有望在保护 MI/R 损伤的临床转化中得到应用。这将为 MI/R 损伤患者带来巨大的福利。